Human TNF RII/TNFRSF1B Antibody, R&D Systems™

TNF RII/TNFRSF1B

Polyclonal

Unconjugated

CD120b, CD120b antigen, Etanercept, p75 TNF receptor, p75TBPII, p75TNFR, soluble TNFR1B variant 1, TNFBRp80 TNF-alpha receptor, TNF-R2, TNFR2TNFR1B, TNF-R75, TNFR80, TNFRII, TNF-RII, TNF-R-II, TNFR-II, TNFRSF1B, tumor necrosis factor beta receptor, tumor necrosis factor binding protein 2, Tumor necrosis factor receptor 2, tumor necrosis factor receptor superfamily member 1B, tumor necrosis factor receptor superfamily, member 1B, Tumor necrosis factor receptor type II

Goat

Affinity Purified

RUO

7133

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot, Flow Cytometry, Neutralization, CyTOF, Immunoassay

LYOPH

Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Neutralization 0.04-0.2 ug/mL, CyTOF-ready, Knockout Validated 5-15 ug/mL

TNFRSF1B

E. coli-derived recombinant human TNF RII/TNFRSF1B

100 μg

Primary

Detects human TNF RII/TNFRSF1B in direct ELISAs and Western blots. In direct ELISAs, less than 50% cross-reactivity with recombinant mouse TNF RII is observed and less than 5% cross-reactivity with recombinant rat TNF RII is observed.

Human

IgG